This study evaluated 254 recovered C19 patients. The results suggest broad and effective immunity may persist long term, and the immune response is highly likely to produce immunity against SARS-CoV-2 variants. https://www.medrxiv.org/content/10.1101/2021.04.19.21255739v1.full-text